.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076092

« Back to Dashboard
NDA 076092 describes KETAMINE HYDROCHLORIDE, which is a drug marketed by West-ward Pharms Int, Hospira, and Mylan Institutional, and is included in three NDAs. It is available from five suppliers. Additional details are available on the KETAMINE HYDROCHLORIDE profile page.

The generic ingredient in KETAMINE HYDROCHLORIDE is ketamine hydrochloride. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ketamine hydrochloride profile page.

Summary for NDA: 076092

Tradename:
KETAMINE HYDROCHLORIDE
Applicant:
Mylan Institutional
Ingredient:
ketamine hydrochloride
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 076092

Physiological EffectGeneral Anesthesia

Suppliers and Packaging for NDA: 076092

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
KETAMINE HYDROCHLORIDE
ketamine hydrochloride
INJECTABLE;INJECTION 076092 ANDA Mylan Institutional LLC 67457-001 67457-001-10 10 VIAL in 1 CARTON (67457-001-10) > 10 mL in 1 VIAL
KETAMINE HYDROCHLORIDE
ketamine hydrochloride
INJECTABLE;INJECTION 076092 ANDA Mylan Institutional LLC 67457-108 67457-108-10 10 VIAL in 1 CARTON (67457-108-10) > 10 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 10MG BASE/ML
Approval Date:Sep 30, 2008TE:APRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 50MG BASE/ML
Approval Date:Dec 28, 2001TE:APRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 100MG BASE/ML
Approval Date:Oct 25, 2002TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc